← Open Payments lookup

NAJIMU AKANJI: Open Payments

NPI 1780391482 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$818 in 43 payments from 12 companies in 2025. Trend: 2023 $465 · 2024 $552 · 2025 $818

Food & beverage: $818
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.16$253
Janssen Pharmaceuticals, Inc4$101
E.R. Squibb & Sons, L.L.C.4$91
Almatica Pharma LLC5$79
Takeda Pharmaceuticals U.S.A., Inc.3$76
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$45
Axsome Therapeutics, Inc.2$41
Neurocrine BioSciences, Inc.1$33
Indivior Inc.1$32
Sage Therapeutics, LLC2$31

Products named: REXULTI, SPRAVATO, COBENFY, LOREEV XR, TRINTELLIX, ABILIFY ASIMTUFII, CAPLYTA, Auvelity.

Industry payments across NV — which companies pay providers there.